Publication:
Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer

Simple item page
dc.contributor.authorsSaip, P.; Eralp, Y.; Ozkan, M.; Karaca, H.; Benekli, M.; Cetin, B.; Isikdogan, A.; Kucukoner, M.; Basaran, G.; Sen, F.; Un, O.; Onur, H.
dc.date.accessioned2022-03-10T17:50:48Z
dc.date.accessioned2026-01-10T20:38:33Z
dc.date.available2022-03-10T17:50:48Z
dc.date.issued2011
dc.identifier.doi10.1200/jco.2011.29.15_suppl.e13079
dc.identifier.eissn1527-7755
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/221397
dc.identifier.wosWOS:000208880303304
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titlePhase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer
dc.typeconferenceObject
dc.type.submeetingabstract
dspace.entity.typePublication
oaire.citation.issue15
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume29

Files

Collections

Araştırma Çıktıları